<DOC>
	<DOCNO>NCT01553175</DOCNO>
	<brief_summary>RATIONALE : Studying sample tumor tissue patient cancer laboratory may help doctor learn change occur DNA find biomarkers related cancer . It may also help doctor find good way treat cancer . PURPOSE : This research trial study gene expression sample patient rhabdoid tumor .</brief_summary>
	<brief_title>Studying Gene Expression Samples From Patients With Rhabdoid Tumors</brief_title>
	<detailed_description>OBJECTIVES : - To determine BRM silenced majority , , rhabdoid tumor immunohistochemistry primary tumor . - To determine BRG1 silenced majority , , rhabdoid tumor immunohistochemistry primary tumor . - To determine GATA1 and/or HDAC2 overexpressed tumor lack BRM expression . - To determine BRM promoter polymorphism correlate loss BRM expression primary rhabdoid tumor . - To determine BRG1 silence primary rhabdoid tumor sequence BRG1 exon genomic DNA derive frozen sample . OUTLINE : Archived tumor tissue sample analyze BRM , BRG1 , GATA1 , and/or HDAC2 expression immunohistochemistry . BRM- BRG1-negative sample also analyze .</detailed_description>
	<mesh_term>Kidney Neoplasms</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Rhabdoid Tumor</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Tumor sample patient diagnose rhabdoid tumor Matched frozen tumor tissue BRG1negative tumor ( prefer ) match genomic DNA tumor , 100 ng per tumor BRG1negative tumor Any source DNA BRG1negative tumor ( tumor , blood , etc . ) Matched frozen tumor tissue BRMnegative tumor confirm BRM mutate alter rather epigenetically suppress lose rhabdoid tumor PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>childhood atypical teratoid/rhabdoid tumor</keyword>
	<keyword>rhabdoid tumor kidney</keyword>
</DOC>